Literature DB >> 20518102

Obesity: Taranabant no longer developed as an antiobesity agent.

Linda Koch.   

Abstract

Year:  2010        PMID： 20518102     DOI： 10.1038/nrendo.2010.56

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  2 in total

1.  A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study.

Authors:  J Proietto; A Rissanen; J B Harp; N Erondu; Q Yu; S Suryawanshi; M E Jones; A O Johnson-Levonas; S B Heymsfield; K D Kaufman; J M Amatruda
Journal:  Int J Obes (Lond)       Date:  2010-03-09       Impact factor: 5.095

2.  A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.

Authors:  L J Aronne; S Tonstad; M Moreno; I Gantz; N Erondu; S Suryawanshi; C Molony; S Sieberts; J Nayee; A G Meehan; D Shapiro; S B Heymsfield; K D Kaufman; J M Amatruda
Journal:  Int J Obes (Lond)       Date:  2010-02-16       Impact factor: 5.095
  2 in total
  4 in total

Review 1.  Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.

Authors:  Marcelo O Dietrich; Tamas L Horvath
Journal:  Nat Rev Drug Discov       Date:  2012-08-03       Impact factor: 84.694

Review 2.  Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.

Authors:  Dennis J Sholler; Marilyn A Huestis; Benjamin Amendolara; Ryan Vandrey; Ziva D Cooper
Journal:  Pharmacol Biochem Behav       Date:  2020-10-18       Impact factor: 3.533

Review 3.  Pharmacotherapy for childhood obesity: present and future prospects.

Authors:  R Sherafat-Kazemzadeh; S Z Yanovski; J A Yanovski
Journal:  Int J Obes (Lond)       Date:  2012-08-28       Impact factor: 5.095

4.  Pharmacotherapies for obesity: past, current, and future therapies.

Authors:  Lisa L Ioannides-Demos; Loretta Piccenna; John J McNeil
Journal:  J Obes       Date:  2010-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.